Search
You have executed a tag search on The Deal Pipeline. Below, you will find a comprehensive list of stories tagged "Pfizer."
12 result(s) displayed (13 - 24 of 40)
Nomura Holdings Inc. hired Andrea Pellegrini as co-chairman for Italy and head of investment banking, partnering with Alessandro Cremona, chairman of investment banking for Italy.... Continue reading
Posted on March 30, 2009 12:00 AM
Recent big-ticket pharma deals illustrate the evolution of financing outs and breakup fees. Continue reading
Posted on March 24, 2009 2:55 PM
The consumer-products subplot in the pharmaceutical megamergers. Continue reading
Posted on March 20, 2009 1:59 PM
As the economy foundered, drug industry insiders looked forward to an M&A frenzy. But with a few exceptions, deals occurred only at the top of the food chain. Continue reading
Posted on March 20, 2009 1:48 PM
Damian Ridealgh and other Fried Frank attorneys advised Merck on its deal for Schering. Continue reading
Posted on March 20, 2009 1:44 PM
Louis Capital's Van Batenburg says the stakes for both companies are high. Continue reading
Posted on March 12, 2009 9:43 AM
From VC to licensing, Exelixis has done every kind of deal to keep itself afloat, except one. Is an acquisition next? Continue reading
Posted on March 6, 2009 11:29 AM
When Mars signed a deal to buy Wrigley, it reserved the right to skip out. That has since become the industry standard. Continue reading
Posted on February 20, 2009 3:24 PM
The media's decided that Wall Street is definitely kaput. Trying to figure what's there instead is more of a problem. Continue reading
Posted on February 20, 2009 3:12 PM
Some financing markets are open, others are closed. The future remains desperately uncertain, but at least the patient shows signs of life. Continue reading
Posted on February 6, 2009 1:30 PM
For sheer drama, Roche's hostile, discounted bid for Genentech tops even Pfizer's bid for Wyeth. Continue reading
Posted on February 6, 2009 1:28 PM
Most noteworthy in the $68B deal may be the size of the reverse termination fee: $4.5B. Continue reading
Posted on February 6, 2009 1:15 PM
Movable Type search results powered by Fast Search
Ken deRegt will retire as head of fixed income at Morgan Stanley and be replaced by Michael Heaney and Robert Rooney. For other updates launch today's Movers & shakers slideshow.
Apax Partners offers $1.1 billion for Rue21, the same teenage fashion chain it took public in 2009. More video
